DM
DOYLE MITTIE disclosed sale in Avalo Therapeutics Inc
DOYLE MITTIE disclosed a sale transaction in Avalo Therapeutics Inc (AVTX) on 2026-05-19.
Action
Sale
Capital
$56,280 reported value
Insider Form 4 Activity1 evidence source
Why it matters
This signal is anchored to the Form 4 disclosure date from Dataroma insider data.